Form 4 for SER Serina Therapeutics, Inc.
Accepted 2025-07-30 00:00:00 ET · period of report 2025-07-29 · accession 0001708599-25-000080 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-30 | 2025-07-29 | SER | Moreadith Randall | CSO | S - Sale+OE | $6.50 | -4,196 | 0 | -100% | -$27.3K |
| D | 2025-07-30 | 2025-07-29 | SER | Moreadith Randall | CSO | M - OptEx | $0.06 | +4,196 | 4,196 | New | +$251.76 |
| D | 2025-07-30 | 2025-07-29 | SER | Moreadith Randall | CSO | M - OptEx | $0.00 | -4,196 | 484.5K | -0.9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-29 | S | D | 4,196 | $6.50 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2025-07-29 | M | A | 4,196 | $0.06 | 4,196 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2025-07-29 | M | D | 4,196 | $0.00 | 484,490 | D | $0.06 · — to 2031-05-06 | 4,196 Common Stock | (F1) The stock options are fully vested. |